# Evaluating the utility of bulk RNA transcriptomics

Canonical: https://abierto.us/opportunities/fdacder25128751

- Solicitation number: FDA-CDER-25-128751
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Seqmatic, LLC
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: July 2, 2025
- Last posted: July 10, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/52d1a274ef7e459c8a725f14f01a5048/view

## Description

The objective of this contract is to obtain service required to complete bulk transcriptomics of RNAs from treated and untreated primary liver hepatocytes. Transcriptomics data generated from bulk RNA sequencing will identify changes occurring for both coding and noncoding RNAs in primary human hepatocytes (PHHs) following treatment. Obtain the service required to complete bulk RNA sequencing or transcriptomics from treated primary liver hepatocytes (PHHS). Transcriptomics data generated from bulk RNA sequencing will quantify expression of both coding and noncoding RNAs in PHHs.

## Award on USAspending

- Recipient: Seqmatic, LLC (UEI T8LRGLKLMMT3)
- Contract: 75F40125P00213, purchase order
- Obligated: $99,900.00
- Competition: Competed Under SAP, 3 offers received
- Link: solicitation number FDACDER25128751 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75F40125P00213_7524_-NONE-_-NONE-/


## Publications

- July 2, 2025: Combined synopsis and solicitation, due July 16, 2025 at 3:00 PM EDT. Notice ebd4756deaef4990a822e050082eaf7f. https://sam.gov/workspace/contract/opp/ebd4756deaef4990a822e050082eaf7f/view
- July 7, 2025: Combined synopsis and solicitation, due July 16, 2025 at 3:00 PM EDT. Notice b639aaad194147b7a262d331ccdeaedc. https://sam.gov/workspace/contract/opp/b639aaad194147b7a262d331ccdeaedc/view
- July 10, 2025: Combined synopsis and solicitation, due July 16, 2025 at 3:00 PM EDT. Notice 52d1a274ef7e459c8a725f14f01a5048. https://sam.gov/workspace/contract/opp/52d1a274ef7e459c8a725f14f01a5048/view

## Points of contact

- Rodney D. Aytch, rodney.aytch@fda.hhs.gov, 2404027515

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdacder25128751.